Trump turns his experimental treatment into another self-promotion stunt
The president’s handling of his COVID treatment kept blurring the line between medicine and campaign spectacle. Instead of calming nerves, the rollout invited more questions about judgment, transparency, and whether the White House was using illness as branding.
The president’s handling of his COVID treatment kept blurring the line between medicine and campaign spectacle. Instead of calming nerves, the rollout invited more questions about judgment, transparency, and whether the White House was using illness as branding.
Truth standard
What TDF can prove
The linked reports preserve their sources, audit notes, confidence rating, corrections, and comments. The page Q&A is restricted to those connected materials and will say when the evidence does not establish an answer.